Mohammad Hashem Hashempur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Hashem Hashempur has a total of 279 co-authors. Here are the top co-authors by number of shared publications:
- Mojtaba Heydari
Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
15 shared publications Seyed Hamdollah Mosavat
Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
8 shared publications- Mesbah Shams
Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
7 shared publications - Seyed Hamdollah Mosavat
Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
6 shared publications - Aida Iraji
Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications - Amir Tajbakhsh
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
The Effect of Fenugreek ( Trigonella foenum‐graecum ) Supplementation on Liver Function Enzymes; a Systematic Review and Meta‐Analysis of Controlled Clinical Trials
Background and Aim: The present systematic review and meta‐analysis aimed to investigate the effect of fenugreek supplementation on key liver enzymes, including alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Method: PubMed, Web of Science, and Scopus databases were searched from 1990 up to April 2025. Clinical trials examining the effects of fenugreek supplements on liver enzymes, specifically ALP, ALT and AST, were included in the study if they met the inclusion criteria. Random‐effects meta‐analysis was employed to calculate pooled weighted mean differences (WMD) and standardized mean differences (SMD) with 95% confidence intervals (95% CI). To evaluate statistical heterogeneity, the I‐squared (I 2 ) statistic was used. Results: Sixteen studies were included, involving a total of 1171 participants. Results indicated that fenugreek supplementation had no significant effect on ALP (SMD = −0.21, 95% CI = −0.44, 0.03), AST (WMD = 0.03 IU/L, 95% CI = –0.12 to 0.18), and ALT (WMD = −1.41 IU/L, 95% CI = −3.07, 0.26). However, a significant reduction in ALP was observed for a dose of more than 1 g/day. Conclusion: Fenugreek didn't affect ALT and AST. However, there is potential benefit at doses ≥ 1 g/day regarding ALP. Further research should investigate effective doses in homogeneous populations and evaluating safety.
- 4 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Open AccessThe Effect of Fenugreek ( Trigonella foenum‐graecum ) Supplementation on Liver Function Enzymes; a Systematic Review and Meta‐Analysis of Controlled Clinical Trials
Background and Aim: The present systematic review and meta‐analysis aimed to investigate the effect of fenugreek supplementation on key liver enzymes, including alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Method: PubMed, Web of Science, and Scopus databases were searched from 1990 up to April 2025. Clinical trials examining the effects of fenugreek supplements on liver enzymes, specifically ALP, ALT and AST, were included in the study if they met the inclusion criteria. Random‐effects meta‐analysis was employed to calculate pooled weighted mean differences (WMD) and standardized mean differences (SMD) with 95% confidence intervals (95% CI). To evaluate statistical heterogeneity, the I‐squared (I 2 ) statistic was used. Results: Sixteen studies were included, involving a total of 1171 participants. Results indicated that fenugreek supplementation had no significant effect on ALP (SMD = −0.21, 95% CI = −0.44, 0.03), AST (WMD = 0.03 IU/L, 95% CI = –0.12 to 0.18), and ALT (WMD = −1.41 IU/L, 95% CI = −3.07, 0.26). However, a significant reduction in ALP was observed for a dose of more than 1 g/day. Conclusion: Fenugreek didn't affect ALT and AST. However, there is potential benefit at doses ≥ 1 g/day regarding ALP. Further research should investigate effective doses in homogeneous populations and evaluating safety.
- 16 July 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179129
The impact of phytochemicals on statin efficacy and safety: A review
- 16 July 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179129
The impact of phytochemicals on statin efficacy and safety: A review
- Open Access
Use of medicinal herbs in an Iranian population: cross-sectional findings from the Fasa PERSIAN Cohort Study
Objectives: To determine the prevalence, patterns and correlates of medicinal herb use in a rural Iranian population and to evaluate demographic and clinical predictors using adjusted regression models. Design: Cross-sectional analysis of baseline data from the Fasa Prospective Epidemiological Research Studies in Iran Cohort Study. Setting: Sheshdeh, a rural district in southern Iran. Participants: 10 143 adults aged 35–70 years enrolled between 2017 and 2019. Primary outcome measures: Prevalence of self-reported medicinal herb use during the past year and its associations with demographic variables and non-communicable diseases (NCDs). Results: Overall, 84.7% of participants (95% CI 83.9% to 85.5%) reported herb use. In multivariable logistic regression, higher educational attainment was positively associated with herb use (university education vs. illiterate: adjusted OR 1.41, 95% CI 1.11 to 1.88). No significant adjusted associations were observed between herb use and major NCDs including diabetes, hypertension, ischaemic heart disease or depression. The most frequently used herbs were Zataria multiflora , Echium amoenum and Matricaria chamomilla , most commonly for anxiety/neurasthenia (81.6%), gastric pain (59.6%) and common cold (49.8%). Conclusions: Medicinal herb use is highly prevalent among adults in southern Iran. Educational level, but not chronic disease status, was associated with herb use. These findings highlight the need for integrated public health strategies regarding safe and evidence-based use of medicinal herbs.
Open AccessUse of medicinal herbs in an Iranian population: cross-sectional findings from the Fasa PERSIAN Cohort Study
Objectives: To determine the prevalence, patterns and correlates of medicinal herb use in a rural Iranian population and to evaluate demographic and clinical predictors using adjusted regression models. Design: Cross-sectional analysis of baseline data from the Fasa Prospective Epidemiological Research Studies in Iran Cohort Study. Setting: Sheshdeh, a rural district in southern Iran. Participants: 10 143 adults aged 35–70 years enrolled between 2017 and 2019. Primary outcome measures: Prevalence of self-reported medicinal herb use during the past year and its associations with demographic variables and non-communicable diseases (NCDs). Results: Overall, 84.7% of participants (95% CI 83.9% to 85.5%) reported herb use. In multivariable logistic regression, higher educational attainment was positively associated with herb use (university education vs. illiterate: adjusted OR 1.41, 95% CI 1.11 to 1.88). No significant adjusted associations were observed between herb use and major NCDs including diabetes, hypertension, ischaemic heart disease or depression. The most frequently used herbs were Zataria multiflora , Echium amoenum and Matricaria chamomilla , most commonly for anxiety/neurasthenia (81.6%), gastric pain (59.6%) and common cold (49.8%). Conclusions: Medicinal herb use is highly prevalent among adults in southern Iran. Educational level, but not chronic disease status, was associated with herb use. These findings highlight the need for integrated public health strategies regarding safe and evidence-based use of medicinal herbs.
- Open Access
Systematic review and meta-analysis of complementary and alternative medicine use during pregnancy in Iran
Objective: This systematic review and meta-analysis aimed to determine the prevalence, patterns and associated factors of complementary and alternative medicine (CAM) use among pregnant women in Iran. Design: A systematic review and meta-analysis of observational studies. Data sources: A comprehensive search was conducted in PubMed/MEDLINE, Web of Science, Scopus, ScienceDirect and major Iranian databases from inception to 30 November 2024. Eligibility criteria for selecting studies: We included observational studies published in peer-reviewed journals that assessed CAM use among pregnant women in Iran and reported prevalence estimates or relevant associated factors. Data extraction and synthesis: Data extraction and quality assessment were performed independently by two reviewers using a standardised form and the Quality Assessment Tool. Meta-analyses of proportions were performed using the DerSimonian and Laird random effects model. The between-study heterogeneity was assessed using the I-squared (I²) statistic. Subgroup analysis, 95% prediction intervals (95% PrIs) and sensitivity analysis were conducted to explore the sources of heterogeneity and to evaluate the robustness of the overall effects, respectively. This study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered with PROSPERO. Results: 20 studies with a total of 8106 participants were included. The pooled prevalence of CAM use was 49% (95% CI 39% to 59%). The between-study heterogeneity was very high (I 2 =94.69%) with a wide 95% PrIs range of 3%–94%. The very high between-study heterogeneity and the wide range of PrI for the pooled prevalence were not explained by the quality of the studies, geographical regions of Iran or the methods of data collection. Mentha longifolia , Zataria multiflora and Boswellia thurifera were the most commonly used herbs. Across the included studies, the first trimester of pregnancy was most frequently reported as the period of CAM use, with socioeconomic factors identified as significant predictors. Family and friends were the primary sources of information regarding CAM. The most common reasons for CAM use included gastrointestinal issues, respiratory problems such as colds and coughs, and the desire to improve general health. Only 31% of participants disclosed their use of CAM to their healthcare provider. Conclusions: Nearly half of pregnant women in Iran use CAM, yet disclosure to healthcare providers is low. An actionable implication is the critical need to integrate routine enquiry about CAM use into standard antenatal care to ensure safe practice. Further research is recommended to evaluate the effectiveness, safety and outcomes of CAM use among pregnant women. PROSPERO registration: CRD42024618490
Open AccessSystematic review and meta-analysis of complementary and alternative medicine use during pregnancy in Iran
Objective: This systematic review and meta-analysis aimed to determine the prevalence, patterns and associated factors of complementary and alternative medicine (CAM) use among pregnant women in Iran. Design: A systematic review and meta-analysis of observational studies. Data sources: A comprehensive search was conducted in PubMed/MEDLINE, Web of Science, Scopus, ScienceDirect and major Iranian databases from inception to 30 November 2024. Eligibility criteria for selecting studies: We included observational studies published in peer-reviewed journals that assessed CAM use among pregnant women in Iran and reported prevalence estimates or relevant associated factors. Data extraction and synthesis: Data extraction and quality assessment were performed independently by two reviewers using a standardised form and the Quality Assessment Tool. Meta-analyses of proportions were performed using the DerSimonian and Laird random effects model. The between-study heterogeneity was assessed using the I-squared (I²) statistic. Subgroup analysis, 95% prediction intervals (95% PrIs) and sensitivity analysis were conducted to explore the sources of heterogeneity and to evaluate the robustness of the overall effects, respectively. This study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered with PROSPERO. Results: 20 studies with a total of 8106 participants were included. The pooled prevalence of CAM use was 49% (95% CI 39% to 59%). The between-study heterogeneity was very high (I 2 =94.69%) with a wide 95% PrIs range of 3%–94%. The very high between-study heterogeneity and the wide range of PrI for the pooled prevalence were not explained by the quality of the studies, geographical regions of Iran or the methods of data collection. Mentha longifolia , Zataria multiflora and Boswellia thurifera were the most commonly used herbs. Across the included studies, the first trimester of pregnancy was most frequently reported as the period of CAM use, with socioeconomic factors identified as significant predictors. Family and friends were the primary sources of information regarding CAM. The most common reasons for CAM use included gastrointestinal issues, respiratory problems such as colds and coughs, and the desire to improve general health. Only 31% of participants disclosed their use of CAM to their healthcare provider. Conclusions: Nearly half of pregnant women in Iran use CAM, yet disclosure to healthcare providers is low. An actionable implication is the critical need to integrate routine enquiry about CAM use into standard antenatal care to ensure safe practice. Further research is recommended to evaluate the effectiveness, safety and outcomes of CAM use among pregnant women. PROSPERO registration: CRD42024618490
- Open Access
- 27 April 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (5)
Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence
Background: Crocus sativus L., commonly known as saffron, is a widely used spice with a rich history of culinary and medicinal applications. This systematic review aims to compile human data from studies on monopreparations of C. sativus , including stigma powder and other extracts, to evaluate their safety. Methods: Databases, including the Web of Science, Scopus, and PubMed Central, were searched up to August 2024 using the keywords “saffron” or “ Crocus sativus ” for clinical trials, case reports, and case series. Results: A total of 102 clinical trials and a single case report were included in this review. Nearly 78% of the trials evaluating the monopreparation of C. sativus addressed safety concerns and reported the complications that occurred. Approximately 56% indicated that one or more adverse effects were experienced during the intervention period. The estimated incidence of adverse events related to C. sativus consumption is around 17.5%. The most frequently reported side effects were gastrointestinal problems, which were minor and self‐limiting in most cases. Conclusion: The findings suggest that C. sativus is generally well tolerated. However, due to some potentially significant adverse events associated with its medicinal use at higher doses or prolonged administration, clinical monitoring should be considered.
- 27 April 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (5)
Open AccessAdverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence
Background: Crocus sativus L., commonly known as saffron, is a widely used spice with a rich history of culinary and medicinal applications. This systematic review aims to compile human data from studies on monopreparations of C. sativus , including stigma powder and other extracts, to evaluate their safety. Methods: Databases, including the Web of Science, Scopus, and PubMed Central, were searched up to August 2024 using the keywords “saffron” or “ Crocus sativus ” for clinical trials, case reports, and case series. Results: A total of 102 clinical trials and a single case report were included in this review. Nearly 78% of the trials evaluating the monopreparation of C. sativus addressed safety concerns and reported the complications that occurred. Approximately 56% indicated that one or more adverse effects were experienced during the intervention period. The estimated incidence of adverse events related to C. sativus consumption is around 17.5%. The most frequently reported side effects were gastrointestinal problems, which were minor and self‐limiting in most cases. Conclusion: The findings suggest that C. sativus is generally well tolerated. However, due to some potentially significant adverse events associated with its medicinal use at higher doses or prolonged administration, clinical monitoring should be considered.
- Open Access
- 11 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 15
Therapeutic potential of Bowman-Birk inhibitors in various disorders: A comprehensive review
- 11 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 15
Open AccessTherapeutic potential of Bowman-Birk inhibitors in various disorders: A comprehensive review
- Open Access
- 30 October 2025
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 20, 1-12
Pharmaceutical and Therapeutic Applications of Royal Jelly for Ocular Surface Diseases: A Comprehensive Review
Ocular surface diseases (OSDs) are conditions that affect the eye’s surface layers, including the cornea, conjunctiva, and glandular network, causing discomfort, visual disturbances, and tear film instability. OSDs include dry eye disease (DED), blepharitis, meibomian gland dysfunction, keratitis, conjunctivitis, and related disorders. These diseases represent a leading cause of ocular morbidity and are often accompanied by chronic inflammation, irritation, redness, and pain. Royal Jelly (RJ), a substance produced by worker bees, has been widely studied in ophthalmology for its therapeutic properties, including its ability to restore tear secretion, treat glaucoma and DED, and inhibit the production of reactive oxygen species (ROS). RJ is rich in proteins, fatty acids, and phenolic compounds, which contribute to its anti-inflammatory, antioxidant, antibacterial, vasodilatory, antitumor, and cholesterol-lowering properties. This review examines the pharmacological benefits of RJ, strategies to optimize its formulation, and methods for developing eye drop formulations—such as microemulsions and eye gels—for the treatment of OSDs. The literature supports RJ as a complementary therapy for OSDs due to its reported anti-inflammatory, antioxidant, and antimicrobial properties. Although preliminary studies are promising, more extensive clinical trials are required to establish standardized treatment protocols and confirm the efficacy and safety of RJ. The therapeutic potential of RJ components lies in their immunomodulatory properties, making them a compelling option for the treatment of OSDs. Further research is necessary to clarify their role in ocular regenerative medicine and expand their applications in clinical practice.
- 30 October 2025
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 20, 1-12
Open AccessPharmaceutical and Therapeutic Applications of Royal Jelly for Ocular Surface Diseases: A Comprehensive Review
Ocular surface diseases (OSDs) are conditions that affect the eye’s surface layers, including the cornea, conjunctiva, and glandular network, causing discomfort, visual disturbances, and tear film instability. OSDs include dry eye disease (DED), blepharitis, meibomian gland dysfunction, keratitis, conjunctivitis, and related disorders. These diseases represent a leading cause of ocular morbidity and are often accompanied by chronic inflammation, irritation, redness, and pain. Royal Jelly (RJ), a substance produced by worker bees, has been widely studied in ophthalmology for its therapeutic properties, including its ability to restore tear secretion, treat glaucoma and DED, and inhibit the production of reactive oxygen species (ROS). RJ is rich in proteins, fatty acids, and phenolic compounds, which contribute to its anti-inflammatory, antioxidant, antibacterial, vasodilatory, antitumor, and cholesterol-lowering properties. This review examines the pharmacological benefits of RJ, strategies to optimize its formulation, and methods for developing eye drop formulations—such as microemulsions and eye gels—for the treatment of OSDs. The literature supports RJ as a complementary therapy for OSDs due to its reported anti-inflammatory, antioxidant, and antimicrobial properties. Although preliminary studies are promising, more extensive clinical trials are required to establish standardized treatment protocols and confirm the efficacy and safety of RJ. The therapeutic potential of RJ components lies in their immunomodulatory properties, making them a compelling option for the treatment of OSDs. Further research is necessary to clarify their role in ocular regenerative medicine and expand their applications in clinical practice.
- Open Access
- 5 October 2025
- Published by Elsevier in Experimental Gerontology
- Vol. 211, 112919
A systematic review and meta-analysis of clinical trials on lavender for sleep disorders in older adults
- 5 October 2025
- Published by Elsevier in Experimental Gerontology
- Vol. 211, 112919
Open AccessA systematic review and meta-analysis of clinical trials on lavender for sleep disorders in older adults